SOPHiA GENETICS (SOPH) Gross Profit (2020 - 2025)

SOPHiA GENETICS has disclosed Gross Profit across 6 years of filings, most recently posting $14.7 million for Q4 2025.

• Gross Profit for Q4 2025 came in at $14.7 million, up 21.4% year-over-year; the trailing twelve-month figure through Dec 2025 was $52.1 million (up 18.53% YoY), and the FY2025 annual result was $52.1 million, up 18.53% from the prior year.
• Gross Profit came in at $14.7 million for Q4 2025 at SOPHiA GENETICS, up from $12.9 million in the prior quarter.
• In the past five years, Gross Profit ranged from a high of $14.7 million in Q4 2025 to a low of $5.6 million in Q1 2021.
• The 5-year median for Gross Profit is $10.2 million (2023), against an average of $9.8 million.
• Peak annual rise in Gross Profit reached 153263.02% in 2021, while the deepest fall reached 99.84% in 2021.
• SOPHiA GENETICS's Gross Profit stood at $6.8 million in 2021, then jumped by 41.01% to $9.6 million in 2022, then increased by 23.54% to $11.9 million in 2023, then increased by 1.71% to $12.1 million in 2024, then rose by 21.4% to $14.7 million in 2025.
• The last three Gross Profit figures came in at $14.7 million (Q4 2025), $12.9 million (Q3 2025), and $12.3 million (Q2 2025), per Business Quant data.